To access the full text documents, please follow this link:

Community pharmacist intervention in depressed primary care patients (PRODEFAR study): randomized controlled trial protocol.
Rubio Valera, Maria; Serrano Blanco, Antoni; Travé i Mercadé, Pere; Peñarrubia María, María Teresa; Ruiz, Mar; March Pujol, Marian
Universitat de Barcelona
Background: Treatment of depression, the most prevalent and costly mental disorder, needs to be improved. Non-concordance with clinical guidelines and non-adherence can limit the efficacy of pharmacological treatment of depression. Through pharmaceutical care, pharmacists can improve patients' compliance and wellbeing. The aim of this study is to evaluate the effectiveness and costeffectiveness of a community pharmacist intervention developed to improve adherence and outcomes of primary care patients with depression. Methods/design: A randomized controlled trial, with 6-month follow-up, comparing patients receiving a pharmaceutical care support programme in primary care with patients receiving usual care. The total sample comprises 194 patients (aged between 18 and 75) diagnosed with depressive disorder in a primary care health centre in the province of Barcelona (Spain). Subjects will be asked for written informed consent in order to participate in the study. Diagnosis will be confirmed using the SCID-I. The intervention consists of an educational programme focused on improving knowledge about medication, making patients aware of the importance of compliance, reducing stigma, reassuring patients about side-effects and stressing the importance of carrying out general practitioners' advice. Measurements will take place at baseline, and after 3 and 6 months. Main outcome measure is compliance with antidepressants. Secondary outcomes include; clinical severity of depression (PHQ-9), anxiety (STAI-S), health-related quality of life (EuroQol-5D), satisfaction with the treatment received, side-effects, chronic physical conditions and sociodemographics. The use of healthcare and social care services will be assessed with an adapted version of the Client Service Receipt Inventory (CSRI). Discussion: This trial will provide valuable information for health professionals and policy makers on the effectiveness and cost-effectiveness of a pharmaceutical intervention programme in the context of primary care. Trial registration: NCT00794196
Atenció farmacèutica
Atenció primària
Depressió psíquica
Anàlisi cost-benefici
Assaigs clínics
Pharmacy practice
Primary health care
Mental depression
Cost effectiveness
Clinical trials
cc-by (c) Rubio Valera, Maria et al., 2009
BioMed Central

Show full item record

Related documents

Other documents of the same author

Rubio Valera, Maria; Serrano Blanco, Antoni; Travé i Mercadé, Pere; Peñarrubia María, María Teresa; Ruiz, Mar; March Pujol, Marian
Rubio Valera, Maria; Bosmans, Judith; Fernández Sánchez, Ana; Peñarrubia María, María Teresa; March Pujol, Marian; Travé i Mercadé, Pere; Bellón, Juan A.; Serrano Blanco, Antoni
Rubio Valera, Maria; March Pujol, Marian; Fernández Sánchez, Ana; Peñarrubia María, María Teresa; Travé i Mercadé, Pere; López del Hoyo, Yolanda; Serrano Blanco, Antoni
Rubio Valera, Maria; Serrano Blanco, Antoni; Magdalena Belío, Jesús; Fernández Sánchez, Ana; García Campayo, Javier; March Pujol, Marian; López del Hoyo, Yolanda
March Pujol, Marian; Via Sosa, Ma. de los Ángeles; Rubio Valera, Maria; Roig Martínez, Marta; Travé i Mercadé, Pere; Martínez Castelao, Alberto; Gorris Teruel, José Luis; Alcázar, Roberto (Alcázar Arroyo); Martinez Fernandez, Isabel